The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

In spite of impressive response rates in multiple cancer types, immune checkpoint inhibitors (ICIs) are active in only a minority of patients. Alternative strategies currently aim to combine immunotherapies with conventional agents such as cytotoxic chemotherapies. Here, we performed a study of PD-1...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Mathe, Doriane, Tourette, Anne, Serre, Laurent, Jordheim, Lars Petter, Matera, Eva Laure, Dumontet, Charles
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2018
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6190749/
https://ncbi.nlm.nih.gov/pubmed/30356816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02100
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak